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We studied the effects of GTP and its’ analogues on PTH release in permeabilized parathyroid cells to assess 
their role in mediating the unusual inverse relationship between CaZ+ and PTH release in intact parathyroid 
cells. Both l&5 M GppNHp and GTPyS, nonhydrolysable analogues of GTP, produce up to an S-fold 
enhancement of PTH release, which is dose-dependent. This effect is specific for GTP analogues as we could 
not mimic it with other nucleotides. 10e3 M GDPfi, a nonhydrolysable GDP analogue, completely abol- 
ishes GppNHp-stimulated hormone release, providing further support for mediation of this effect by a guan- 
ine-nucleotide regulatory protein. In GppNHp-stimulated cells, PTH release is maximal at free [CaZ+] less 
than 200 nM and progressively decreases as the free [Ca”] increases from 300 nM to 100 PM. These results 
suggest the presence of a guanine-nucleotide binding protein in the parathyroid cell that may play an impor- 
tant role in the regulation of PTH secretion by CaZ+ and perhaps other secretagogues. 
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1. INTRODUCTION 
The parathyroid cell is unusual for its inverse 
relationship between both the extracellular [l] and 
cytosolic [2,3] Ca2+ concentrations and PTH 
release. This relationship is the opposite of 
classical stimulus-secretion coupling [4] in that 
high Ca2+ concentrations inhibit rather than 
stimulate PTH secretion. The mechanisms 
underlying the inhibitory effects of Ca2+ on PTH 
release remain obscure. Recent work has suggested 
that extracellular Ca2+ and other polyvalent 
cations may interact with a ‘receptor’ or ‘sensor’ 
on the plasma membrane of the parathyroid cell, 
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Guanine nucleotide-stimulated PTH release is maximal 
at low free Ca’+ (10e9 to 2.4 x 10m7) (see fig.5, below). 
Low free Ca2+ concentrations were used, therefore, in 
these and subsequent experiments unless otherwise in- 
dicated 
which regulates the permeability of the membrane 
to K+ [5] as well as Ca2+ [3,6,7]. In addition, PTH 
secretion appears to be closely related to a variety 
of intracellular second messengers, including 
CAMP [S], cytosolic Ca2+ [2], and diacylglycerol 
[9]. In many systems, the interactions of ex- 
tracellular ligands with cell surface receptors is 
transduced into intracellular signals via guanine- 
nucleotide binding proteins (N proteins) [lo]. It is 
possible, therefore, that N proteins might play a 
role in the recognition of changes in the ex- 
tracellular Ca2+ concentration by the parathyroid 
cell. In fact, Fitzpatrick and Aurbach [l l] have 
reported recently that preincubation with pertussis 
toxin prevents the inhibitory effects of Ca2+ on 
PTH release. In the present studies, we have in- 
vestigated further the potential role of N proteins 
in PTH release using parathyroid cells permeabil- 
ized by electroshock [12]. In this model system, ex- 
tracellular guanine nucleotides have direct access 
to the secretory apparatus, and we demonstrate 
that nonhydrolysable analogues of GTP have po- 
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tent stimulatory effects on PTH release which are 
inhibited by physiologically relevant Ca2+ concen- 
trations. 
2. MATERIALS AND METHODS 
Dispersed bovine parathyroid cells are prepared 
by enzymatic digestion of minced parathyroid 
tissue from calves as described [8]. The cells are 
then washed three times with Eagle’s minimal 
essential medium (bicarbonate, Ca2+ and Mg*+ 
deleted) with 20 mM Hepes, 1.5 mM CaCl2, 
0.5 mM MgS04 and 0.1% (w/v) BSA, pH 7.4 
(274 mOsm). After the final wash, the cells needed 
for a given experiment are resuspended in 1 ml of 
a solution containing 119.3 mM potassium 
glutamate, 5 mM ATP, 7 mM Mg acetate, 
4.3 mM glucose, 17.2 mM K Pipes, pH 6.9, 1 mM 
EGTA and 0.1% BSA (‘K-Glu’; 272 mOsm). The 
cell suspension is then placed in a plexiglass well, 
1.5 cm deep and 1.5 cm wide, containing two 
stainless steel electrodes positioned 0.5 cm apart. 
The cells are shocked 5 times at 10-s intervals using 
a reconditioned Hewlett-Packard cardiac 
defibrillator which delivers 2 kV over 200 ps. Cells 
permeabilized in this fashion are unchanged mor- 
phologically by light microscopy. In addition, at 
least 90% of the permeabilized cells take up trypan 
blue (Mr 961) for a minimum of 60 min, versus 5% 
or less of control (nonpermeabilized) cells in- 
cubated in the same medium. Finally, shocked cells 
lose 90% of cellular 86Rb taken up during an hour 
preincubation within 1.5 min after electroshock 
(vs 5-10% for control cells), thereby showing 
bidirectional movement of small solutes across the 
plasma membrane following cell permeabilization. 
After permeabilization the cells are removed and 
collected at a final concentration of 2 x lo6 
cells/ml into 5 ml incubation vials containing K- 
Glu with varied Ca*+ concentrations with or 
without other agents as detailed in section 3. After 
incubation for varying durations at 37°C in a 
metabolic incubator, the cells and media are 
sedimented in a desktop centrifuge at 100 x g for 
2 min. PTH in the supernatant is determined by 
RIA as published before, using either an antiserum 
recognizing intact bPTH( l-84) and C-terminal 
fragments of the hormone (GW-1) or another 
antiserum (CK-13; generously provided by Dr 
G.V. Segre) recognizing the intact hormone and N- 
100 
terminal fragments of PTH [ 131. Unless otherwise 
indicated, the results given below were measured 
by C-terminal assay. CAMP in the cellular pellet 
was extracted with TCA and measured by RIA 
[ 141. The Ca2+ concentrations in incubation media 
were determined by a Ca*+ sensitive microelec- 
trode as used by Levy and Fein [ 151. Lactate 
dehydrogenase (LDH) activity was measured using 
a kit (Sigma, St. Louis, MO, cat.no.500). Results 
were evaluated using the unpaired Student’s t-test 
and statistical significance was assigned to P values 
< 0.05. 
3. RESULTS 
As shown in fig.1, PTH release from 
permeabilized parathyroid cells under basal condi- 
tions gradually increases from 0.38 * 0.08 at 5 min 
to 1.26 * 0.14 ng/lO’ cells at 60 min. Conversely, 
in the presence of 10m5 M GppNHp, there is an 
8.2-fold enhancement of PTH release above basal 
values to 3.16 f 0.55 ng/105 cells at 5 min, and 
hormone release rises slightly to 3.75 + 
0.39 ng/105 cells at 15 .min. The stimulation of 
PTH release with GppNHp is dose-dependent be- 
tween 3 x lo-’ and 10m4 M (fig.2). In contrast to 
the effects of GppNHp in permeabilized cells, in- 
cubation of intact, nonpermeabilized parathyroid 
cells with 10m5 M GppNHp had no effect on PTH 
secretion. As shown in fig.2, GTP+, another 
20 40 60 
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Fig.1. Time course for basal and GppNHp-stimulated 
PTH release. Parathyroid cells were permeabilized as 
described in section 2 and incubated in K-Glu with or 
without 10m5 M GppNHp for 5 to 60 min. At the end of 
the experiment, the cells were sedimented and PTH in 
the supernatant was assayed by RIA. Each point 
represents the mean + SE for 3 experiments each 
performed in triplicate and assayed in duplicate. 
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Fig.2. Dose-response curves for the effects of GppNHp 
and GTPrS on PTH release. Permeabilized parathyroid 
cells were incubated in varied concentrations of the 
nonhydrolysable GTP analogues for 15 min and PTH 
was measured by RIA as described above (N = 4-15). 
nonhydrolysable analogue of GTP, also produces 
a dose-dependent rise in PTH release between 10e9 
and 10m4 M. At 1O-4 M GTPyS, the increment in 
PTH release above control is similar to that 
observed with equimolar concentrations of 
GPPNHP. 
In 3 experiments, the release of LDH from 
permeabilized parathyroid cells was slightly, but 
not significantly, higher than from unshocked 
cells. GppNHp (IO-’ M) had no significant effect 
on LDH release (not shown), suggesting that 
GppNHp did not increase hormone release by 
causing nonspecific release of cellular contents. In 
addition, GppNHp-enhanced PTH release as 
measured by an N-terminal assay was comparable 
to or greater than that observed using a C-terminal 
assay (not shown), consistent with stimulation of 
the release of intact hormone. 
Guanine nucleotide-enhanced hormone release 
is specific for guanine nucleotide triphosphates as 
the effect is not mimicked by the GDP analogues 
GDP,&S, GDP, CTP, or UTP (fig.3). Of note, 
GTP does not significantly increase PTH release in 
permeabilized cells, most likely because it is rapid- 
ly cleaved by intracellular GTPases. cGMP (not in- 
cluded here) also had no significant effect on PTH 
release compared to control cells (P > 0.05). To 
assess whether GDP/B might compete with GTP 
for an intracellular guanine-nucleotide binding 
site, we incubated permeabilized parathyroid cells 
with 10m5 M GppNHp and varied concentrations 
of GDP@. As shown in fig.4, 10m5 M GDP,&S at- 
tenuates the GppNHp-enhanced hormone release 
by 50% (from 2.73 +_ 0.38 to 1.36 t- 0.36 ng/l05 
cells) and 10m3 M GDP@ totally abolishes 
GppNHp-stimulated PTH release (fig.4). 
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Fig.3. The effects of different nucleotides on PTH 
release. Permeabilized parathyroid cells were incubated 
with each of the nucleotides shown for 15 min and PTH 
was measured by RIA. None of these nucleotides 
produced any significant stimulation of PTH release 
compared to the control (N = 9-18). 
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Fig.4. The effects of the GDP analogue GDPpS on 
GppNHp-stimulated PTH release. Incubations of 
permeabilized parathyroid cells were carried out under 
control conditions as well as in the presence of lo-’ M 
GppNHp with or without varied concentrations of 
GDPfiS for 15 min using the methods described above 
(N = 9-12). 
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To evaluate the possibility that this guanine 
nucleotide-stimulated hormone release in permea- 
bilized cells might account for the enhanced secre- 
tion of PTH at low free Ca2+ and inhibition at 
higher Ca2+ concentrations in intact parathyroid 
cells, we examined the effects of Ca2+ on basal and 
GppNHp-stimulated hormone release (fig.5). As 
demonstrated previously, cells incubated with 
Ca’+ alone exhibit little change in PTH release at 
Ca2+ concentrations less than 10e6 M, and PTH 
release increases 2-fold at higher Ca2+ concentra- 
tions, with half-maximal and maximal values at 
10m5 and 10m4 M, respectively [12] (fig.5). Con- 
versely, in GppNHp-stimulated cells, PTH release 
is maximal at low free Ca2+ concentrations, rang- 
ing from 10e9 to -2.4 x lo-’ M, and is inhibited 
progressively as the free [Ca2’] increases from 3 x 
lo-’ M to 1OOpM. 
To investigate possible cellular mechanisms 
underlying the stimulatory effects of GppNHp on 
hormone release, we evaluated the effect of this 
GTP analogue on CAMP content because of the 
known role of guanine-nucleotide regulatory pro- 
teins in coupling the interaction between receptcrs 
and adenylate cyclase [lo]. GppNHp (1 0m5 M) pro- 
duced a 1.98-fold rise in cellular CAMP content in 
permeabilized parathyroid cells at 5 min (N = 
B-9), in the presence of a 6-fold rise in PTH 
release. Isoproterenol (10m5 M), however, which 
h - 
9876543 
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Fig.5. The effects of varied free Ca2+ concentrations on 
basal and guanine nucleotide-stimulated PTH release. 
Permeabilized parathyroid cells were incubated for 
5 min in K-Glu with Ca-EGTA buffers so as to attain 
free Ca2+ concentrations ranging from 1O-9 to 10m4 M 
and PTH was determined in the supernatant (N = 9). 
elevates CAMP in intact parathyroid cells [8] in- 
creased CAMP levels 5-fold in permeabilized cells 
at 5 min but had little or no effect on PTH release. 
Thus, changes in CAMP cannot account quan- 
titatively for the effects of GppNHp on PTH 
release. 
4. DISCUSSION 
Unlike classical stimulus-secretion coupling, 
high Ca2+ concentrations inhibit rather than 
stimulate PTH release in the parathyroid cell due 
to poorly defined mechanisms. Previous studies of 
parathyroid cell secretory function have been per- 
formed using intact cell preparations and have 
been hindered by the complex ionic gradients 
across the plasma membrane and the lack of direct 
access to the internal cellular environment and the 
secretory apparatus. To elucidate the mechanisms 
underlying the control of exocytosis in the 
parathyroid cell, we have recently developed a 
system of permeabilized parathyroid cells using a 
method of electroshock [16]. In examining the ef- 
fects of Ca2+ on PTH release, we were surprised to 
observe that in the parathyroid cell, like other cells 
showing classical stimulus-secretion coupling, high 
free Ca2+ concentrations increase PTH release 
2-3-fold, with half-maximal stimulation occurring 
at 10m5 M Ca2+ [12]. However, over the 
physiologic range of cytosolic free Ca2+ concentra- 
tions in the intact parathyroid cell (lo-’ to 10m6 M 
as measured with quin2 [2]), PTH release is low 
and Ca’+ has no effect on the secretion of hor- 
mone. Moreover, these low secretory rates for 
PTH cannot account for the enhanced PTH secre- 
tion observed at reduced extracellular Ca2+ con- 
centrations in the intact cell, which are associated 
with intracellular free Ca2+ concentrations of 
100-200 nM. These studies reveal that the basic 
blueprint for secretion in the parathyroid cell is 
similar to other exocytotic cells, and therefore, 
mediators other than or in addition to cytosolic 
Ca2+ must invert the secretory response to Ca2+ in 
the intact parathyroid cell. 
In the present investigations, we demonstrate 
that the nonhydrolysable analogues of GTP, 
GppNHp and GTP+, produce a dose-dependent 
stimulation of PTH release which is specific for 
GTP analogues, providing support for mediation 
of this effect by a guanine-nucleotide regulatory 
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protein. In addition, 10V3 M GDPPS completely 
abolishes the GppNHp-enhanced hormone release. 
These data concur with similar observations in 
other permeabilized cell systems and further sug- 
gest that GDPpS may be interacting with a GTP 
binding site on a guanine-nucleotide regulatory 
protein in the parathyroid cell [17]. 
We also examined the effects of Ca*+ on 
GppNHp-stimulated hormone release. At low 
Ca*+ concentrations (52.4 x 10m7 M), equivalent 
to those in the intact cell at reduced extracellular 
Ca*+, PTH release is maximal at -3-4 ng/105 cells 
(figs 1,5). This rate of PTH release in the presence 
of guanine nucleotide can readily account for that 
observed at low extracellular Ca*+ concentrations 
(-3-5 ng/lO’ cells/h) in the intact parathyroid cell 
[ 181. Moreover, there is a progressive decrease in 
guanine nucleotide-stimulated hormone release as 
the free Ca*+ concentrations increase from 300 nM 
to as high as 100 PM in permeabilized parathyroid 
cells. This is phenomenologically similar to the 
Ca*+-induced suppression of PTH secretion in 
nonpermeabilized cells. The inhibitory effects of 
Ca*+ on PTH release in intact parathyroid cells, 
therefore, may result from a Ca*+-induced reduc- 
tion in guanine nucleotide-stimulated PTH secre- 
tion either via inhibition of a stimulatory N protein 
and/or, as suggested by Fitzpatrick and Aurbach 
[ill, activation of an antagonist guanine- 
nucleotide regulatory protein. 
Guanine-nucleotide binding proteins transduce 
extracellular signals into a variety of intracellular 
events. The GppNHp-induced rise in intracellular 
CAMP in permeabilized cells, presumably 
mediated via activation of Ns [lo] (the guanine- 
nucleotide regulatory protein activating adenylate 
cyclase) is one possible mechanism for the effects 
of guanine nucleotides on PTH release. 
lsoproterenol, however, which produces an even 
larger rise in CAMP, has essentially no effect on 
PTH, indicating that GppNHp must act via other 
mechanisms. The lack of effect of isoproterenol on 
PTH release in permeabilized cells contrasts with 
its potent stimulatory effects on PTH secretion 
from intact parathyroid cells, suggesting that the 
intracellular mechanisms underlying the actions of 
CAMP on PTH release are not active in 
permeabilized cells. Other possible mechanisms 
through which GppNHp might modify PTH 
release include effec?s on an ion channel [19], ac- 
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tivation of phospholipase C [20] resulting in 
stimulation of protein kinase C and/or direct ef- 
fects on secretion [17]. 
In summary, nonhydrolysable GTP analogues 
are potent secretagogues in permeabilized 
parathyroid cells. The nucleotide specificity of this 
effect and the inhibition of guanine nucleotide- 
stimulated hormone release by GDP,&S and by high 
Ca*+ suggest that a guanine-nucleotide regulatory 
protein in intact parathyroid cells may play an im- 
portant role in the regulation of PTH secretion. 
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